Clinical Trial Update: Randomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating Agents in Myeloid Malignancies [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluating conditioning with fludarabine plus single versus dual alkylating agents in myeloid malignancies (acute myeloid leukemia an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Alkylating agents (single or dual) (alkylating agents)
• Fludarabine (Fludarabine)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 3 | Status: RECRUITING